[go: up one dir, main page]

Ozand et al., 1990 - Google Patents

Aspartoacylase deficiency and Canavan disease in Saudi Arabia

Ozand et al., 1990

Document ID
4651029948649462139
Author
Ozand P
Gascon G
Dhalla M
Publication year
Publication venue
American journal of medical genetics

External Links

Snippet

We found defective aspartoacylase activity in fibroblasts cultured from 12 patients with leukodystrophy clinically diagnosed as spongy degeneration of the brain (Canavan disease), three confirmed by brain biopsy. The activity of aspartoacylase ranged between 1 …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Hybridisation probes
    • C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases

Similar Documents

Publication Publication Date Title
Ozand et al. Aspartoacylase deficiency and Canavan disease in Saudi Arabia
Shapiro et al. A prospective natural history study of mucopolysaccharidosis type IIIA
Ciafaloni et al. Maternally inherited Leigh syndrome
Brockmann et al. Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency
Renlund et al. Salla disease: a new lysosomal storage disorder with disturbed sialic acid metabolism
Matalon et al. Biochemistry and molecular biology of Canavan disease
Bass et al. A pedigree study of metachromatic leukodystrophy: Biochemical identification of the carrier state
Baumgartner et al. Clinical approach to inherited peroxisomal disorders: a series of 27 patients
Ozand et al. Prevalence of different types of lysosomal storage diseases in Saudi Arabia
Haataja et al. Phenotypic variation and magnetic resonance imaging (MRI) in Salla disease, a free sialic acid storage disorder
McGeer et al. Correlations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease
Nagy et al. Canavan disease
Pekgül et al. Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives
De Koning et al. Pontocerebellar hypoplasia associated with respiratory-chain defects
Matalon et al. Recent advances in Canavan disease
Baumann et al. Adult-onset leukodystrophies
US6183981B1 (en) Diagnostic assay for late-onset Alzheimer's disease
Phelan et al. Pediatric neurodegenerative white matter processes: leukodystrophies and beyond
Greco et al. Infantile Krabbe disease (0–12 months), progression, and recommended endpoints for clinical trials
Grover et al. Clinical variation in 2 related children with neuronopathic Gaucher disease
Gilchrist et al. The evaluation of infants with the Zellweger (cerebro‐hepato‐renal) syndrome
Loonen et al. Identification of heterozygotes for glycogenosis 2 (acid maltase deficiency)
Ricci et al. Biochemical characterization on muscle tissue of a novel biallelic ACO2 mutation in an infant with progressive encephalopathy
Landau et al. A novel mutation in the SLC17A5 gene causing both severe and mild phenotypes of free sialic acid storage disease in one inbred Bedouin kindred
Hreidarsson et al. Impaired cerebroside sulfate hydrolysis in fibroblasts of sibs with “pseudo” arylsulfatase A deficiency without metachromatic leukodystrophy